Ease Labs plans $30M expansion to enter cannabis exports from Brazil
Brazilian producer Ease Labs is expanding with $30M investment aimed at export operations as domestic medical market approaches $500M annually.
FILE — harvest · My 420 Tours / CC BY-SA 4.0Ease Labs has announced a $30M expansion plan focused on cannabis exports, according to reporting from Valor International. The move signals growing confidence in Brazil's ability to serve international markets even as the domestic medical sector continues to mature.
Brazil's medical cannabis industry generated approximately R$485M (roughly $90M USD) annually and serves around 1 million patients, per recent market assessments. Import authorizations have risen 29% and regulatory infrastructure—including upgraded testing standards and a new germplasm bank—continues to develop, suggesting the market may be stabilizing sufficiently to support export-oriented production.
Watch whether Ease Labs secures export partnerships or regulatory clearances in target markets, and whether this expansion signals broader industry confidence in Brazil-based cultivation and processing scaling beyond domestic pharmaceutical demand.
Original report: Valor International ↗